K. AKTORIES and G. KOCH
ADP-ribosyltransferase C3 is an exoenzyme produced by several strains of Clostridium botulinum. It was serendipitously detected during screening for high producer strains of C. botulinum C2 toxin (Aktories et al., 1987; Aktories et a/., 1988b). The novel ADP-ribosyltransferase was termed C. botulinum ADP-ribosyltransferase C3, because it proved to be distinct from C. botulinum neurotoxin CI and the actin ADP-ribosylating C. botulinum C2 toxin. C3 ADP-ribosylates members of the Rho protein family at asparagine-41 thereby inactivating the GTP-binding protein. Therefore, C3 ADP-ribosyltransferase has become a molecular tool to study the function of Rho proteins.
The C3 ADP-ribosyltransferase gene was shown to be located on a DNA bacteriophage together with neurotoxin CI and D (Popoff eta/., 1991; Hauser et al., 1993). Various isoforms of the C3 transferase have C3 isoforms been described (Popoff et al., 1990; Nemoto et al., 1991; Popoff et al., 1991; Moriishi et al., 1991; Moriishi et al., 1993). Whereas the gene for C3 from C. botulinum strain C468 encodes a protein of 211 amino acids (without signal peptide) with a molecular mass of 23546 Da (Popoff et a I., 1990; Popoff etal., 1991), C3 from C. botulinum strain C 003-9 encodes a protein of 204 amino acids with a molecular mass of 23119 Da (Nemoto etal., 1991) showing about 65% identity with the other C3 isoform. Moreover, C3-related transferases are produced by Clostridium limosum (C. limosum exoenzyme) (Just et al., 1992a), Staphylococcus aureus (EDIN: epidermal differentiation inhibitor) (Inoue etal., 1991), and Bacillus cereus (8. cereus exoenzyme) (Just et al., 1992b; Just etal., 1995). Amino acid sequences of the transferases from C. limosum and S. aureus (EDIN) are about 63 % and 30 % identical with those from C. botulinum strains, respectively. So far, the transferase from B. cereus has not been cloned. Partial amino acid analysis indicates that this transferase is rather distantly related to other C3-like toxins. All C3-like tranferases are 23-28 kDa proteins with a high content of basic amino acids (pi 9-10). C3 transferase is rather heat stable (1 min, 95°C) and is resistant to short-term trypsin treatment (Aktories etal., 1987).
Recently, the active site of C3-like transferases has been identified. It was shown that Glul74 of C. botulium C3 transferase (strain C468; Glu 173 in strain 0003-9) is a catalytic important glutamic acid residue, which is strictly conserved in all bacterial ADP-ribosyltransferases studied so far (Jung et a/., 1993; Aktories et a/., 1995; Böhmer et a/., 1996; Saito et a/., 1995). Interestingly, it was found that C3 like transferases show a significant degree of sequence similarity (especially in the region around the catalytic site) with various eukaryotic ADP-ribosyltransferases like rabbit muscle ADP-ribosyltransferase (Oka-zaki etal., 1994) and the family of RT6-like transferases (Koch-Nolte et al„ 1996).
5.3 Modification of Rho Proteins by C3-like Transferases
Rho proteins belong to a subfamily of low molecular mass GTPases that include RhoA,B,C, Racl,2, Cdc42 (G25K), RhoG and TC10 (for review see references: Nobes and Hall, 1994; Hall, 1994; Takai et al., 1995; Machesky and Hall, 1996). At the amino acid level, Rho subfamily proteins are about 55% identical to each other and about 30% identical to Ras proteins. Like other regulatory GTPases (Bourne etal., 1990; Bourne etal., 1991), Rho subfamily proteins are inactive in the GDP bound form and active with GTP bound (Fig. 1). Activation is induced by nucleotide exchange factors (GEF), also called guanine nucleotide dissociation stimulators (GDS) (Feig, 1994; Quilliam et al., 1995; Overbeck etal., 1995; Quilliam etal., 1995). In the active state, Rho subfamily proteins interact with their specific effectors (more than ten potential effectors have been identified and their number is still growing) which appear to be involved in various regulatory processes (see below). The active state of Rho proteins is terminated by hydrolysis of GTP catalyzed by their endogenous GTPase activity. The basal GTPase activity is very low, but is dramatically increased by GAP proteins (GTPase-stimulating proteins) (Lamarcheand Hall, 1994). Finally, Rho subfamily proteins are regulated by guanine nucleotide dissociation inhibitors (GDI), which inhibit nucleotide exchange. GDI proteins are able to prevent binding of Rho subfamily proteins to membranes where, it is suggested, they act (Isomura et al., 1991). functions of Rho proteins are involved in regulation of the actin cytoskeleton Rho proteins and induce formation of stress fibers and focal adhesions (Paterson et al., 1990; Ridley and Hall, 1992; Tominaga et al., 1993; Laudanna et al., 1996). Most probably independently of their role in actin regulation, Rho proteins have been proposed to participate as molecular switches in the control of phosphoinositide-3-kinase (Zhang et al., 1993), phosphatidylinositol-4-phosphate-5-kinase (Chong et al., signal input
inactive signal input inactive
- stress fiber formation
- ceil adhesion
- cell morphology
- cell motility smooth muscle /if contraction endocytosis cell-cell contact
A PI-3-kinase PIP-5-kinase phospholipase D
transcriptional activation inhibition of Rho dependent processes
Fig. 1. ADP-ribosylation of Rho by C3 transferases. Rho proteins are regulated by a GTPase cycle. The GTP-binding proteins are inactive with GDP bound, and active in the GTP-bound form. GDP/GTP exchange is facilitated by guanine nucleotide dissociation stimulator(s) (GDS) and inhibited by guanine nucleotide dissociation inhibitor(s) (GDI). In the active form, Rho protein interacts with its effector(s) and induces several cellular responses, one of which is polymerization of actin. Rho is ADP-ribosylated by C3 transferases at asparagine-41. Most likely, the modification inhibits the interaction of Rho with its effector(s) which results in inhibition of Rho dependent processes (e.g. F-actin depolymerization)
1994), phospholipase D (Malcolm et al., 1994), myosin phosphatase (Kimura et al., 1996) and smooth muscle contraction (Hirata et al., 1992), cell-cell contact (Tominaga et al., 1993) and endocytosis (Schmalzing eta/., 1995). Furthermore, Rho subtype proteins may play a role in transcriptional activation (Olson eta/., 1995; Hill etai, 1995), and in the transformation of cells induced by the oncogene product Ras (Khosravi-Far eta/., 1995; Qiu etal., 1995).
Rac proteins (Racl,2), which are also members of the Rho sub- functions of Rac and family, are involved in membrane ruffling and lamellipodia formation Cdc42 proteins induced by growth factors (Ridley et al., 1992; Hall, 1994), and it has also been suggested that they are important for Ras-induced transformation (Qiu etal., 1995). Moreover, Rac proteins control NADPH oxidase (Abo et al., 1991; Bokoch, 1994), and may have a role in phospholipase A2 regulation (Peppelenbosch et al., 1995). Cdc42, another member of the Rho family, which occurs in at least two iso-
forms, participates in receptor-induced formation of microspikes and filopodia (Nobes and Hall, 1995; Kozma etal., 1995). substrate specificity of C3 C3 shows a remarkable substrate specificity and modifies RhoA, B,
C (Hall, 1994; Paterson et a/., 1990; Chardin et a/., 1989; Wiegers et a/., 1991; Aktories et a/., 1989; Braun et a/., 1989), while other members of the Rho subfamily are poorly modified (e.g. 5-10% ADP-ribosylation of Rac in the presence of 0.01 % SDS), or not at all (Cdc42) (Just et al., 1992a). Other low molecular mass GTP-binding proteins or heterotrimeric G-proteins are not substrates for C3. The other C3-like transferases appear to share the same substrate specificity. C3-like transferases ADP-ribosylate Rho proteins at asparagine-41 (Sekine etal., 1989). Asparagine-41 is located in the effector region of the small GTP-binding proteins and attachment of the bulky ADP-ribose group by ADP-ribosylation may inhibit the interaction of Rho with its effectors. Alternatively, ADP-ribosylation may affect the activation of the Rho protein by guanine nucleotide exchange factors.
5.4 Characterization of the C. botulinum C3 ADP-Ribosyltransferase Reaction
Like other bacterial ADP-ribosylating toxins (e.g. diphtheria toxin, Pseudomonas aeruginosa exotoxin A, cholera toxin, pertussis toxin, and C botulinum C2 toxin (Aktories and Just, 1993)), C3 is a mono-ADP-ribosyltransferase (Aktories et al., 1988b). Treatment of ADP-ribosylated Rho with phosphodiesterase releases 5'-AMP and not phosphoribosyl-AMP, a cleavage product of poly(ADP-ribose) (Aktories etal., 1988b; Rubin etal., 1988). Accordingly, thymidine, an inhibitor of poly(ADP-ribose)polymerase, does not block C3-like ADP-ribosyltransferases, and can be included in C3 ADP-ribosylation assays to block poly-ADP-ribosylation reactions.
Asparagine is unique as an acceptor amino acid for ADP-ribosylation by C3-like transferases (Sekine et al., 1989). In contrast, pertussis toxin modifies cysteine residues, and cholera toxin and C. botulinum C2 toxin specifically ADP-ribosylate arginine residues (for details see the relevant chapters). The ADP-ribose-asparagine bond formed by C3-like transferases is stable towards neutral hydroxyl-amine (0.5 M, 2h) and mercury ions (2mM, 1 h), whereas cysteine and arginine-specific ADP-ribosylation, respectively, are sensitive towards these agents (Aktories etal., 1988a).
ADP-ribosylation by C3 and its isoenzymes is a reversible reaction, i.e. in the presence of high concentrations of nicotinamide (10mM) and at low pH (pH <7) it can be reversed (Habermann et al., 1991). The de-ADP-ribosylation reaction has been exploited to identify the acceptor amino acid of ADP-ribosylation by C3-like isoforms. Like other ADP-ribosyltransferases, C3-like exoenzymes exhibit NAD gly-cohydrolase activity (Aktories et al., 1988b). However, this enzyme activity is at least 100-fold lower than the transferase activity and most likely has no physiological significance.
In principle, ADP-ribosylation of Rho by C3 needs no other factors in addition to Rho and NAD (for review see also (Aktories and Just, 1995)). Rho is ADP-ribosylated in intact cells, in cell lysate (membranes and cytosol), and as a recombinant protein. Even Rho-gluta-thione S-transferase fusion proteins are substrates for ADP-ribosylation by C3. ADP-ribosylation by C3 is affected by guanine nucleotides, divalent cations, detergents and temperature. Purified endogenous Rho, recombinant Rho proteins, and the membranous Rho protein are better substrates for ADP-ribosylation when bound to GDP rather than GTP (Habermann et a/., 1991). In contrast, ADP-ribosylation of cytosolic Rho is enhanced by addition of GTPyS or GTP (Williamson etal., 1990). It is suggested that the nucleotides facilitate dissociation of RhoGDI, because affinity of GTP-bound RhoA for RhoGDI is lower than of GDP-bound RhoA (Kikuchi et a/., 1992; Regazzi et a/., 1992; Bourmeyster et a/., 1992). Free Rho protein is a better substrate for C3 than Rho complexed with RhoGDI. Similarly, C3 ADP-ribosylation of cytosolic or partially purified Rho protein is increased in the presence of detergents (sodium cholate, deoxycho-late) or phospholipids (phosphatidylinositol bisphosphate). This suggests that detergents and phospholipids dissociate the complex between RhoGDI and Rho protein and provide access for C3-like exoenzymes to ADP-ribosylate Rho (Bourmeyster et a/., 1992; Just et a/., 1993). In the absence of GDI, C3-catalyzed ADP-ribosylation is also affected by various detergents. Sodium cholate (0.2%), deoxy-cholate, dimyristoylphosphatidylcholine (3mM), and SDS (0.01 %) increase C3-catalyzed ADP-ribosylation. In contrast, CHAPS, Lubrol-PX, and SDS (>0.03%) impair ADP-ribosylation (Just et a/., 1992a; Just etal., 1993; Maehama etal., 1990).
5.6 C3-Transferases in Cell Biology and Pharmacology
In intact animals, toxicity of C3 is low compared with other toxins that low toxicity of C3 affect Rho proteins. Intraperitoneal injection of 100 fig of C3 into mice is apparently without obvious consequences. (Note that the minimum lethal dose of C. difficile toxins A and B, which also modify Rho proteins, is about 50 ng per mouse). C3-like transferases appear to lack any specific cell-binding or transport subunits, a fact that calls into question the designation of these exoenzymes as toxins. However, when these bacterial exoenzymes reach the eukaryotic cytosol (e.g. by unspecific uptake or microinjection, see below) they are potent cytotoxins (Wiegers etal., 1991; Didsbury etal., 1989; Chardin et a/., 1989; Paterson et a/., 1990). Thus, the use of C3 toxin as a cell biological tool is hampered by the fact that C3 is not able to enter cells readily. The problem of cell accessibility was first by-passed by using osmotic shock to introduce C3 into cells (Rubin et al., 1988). Many excellent studies from the laboratory of Alan Hall have been performed using the microinjection technique (Paterson et al., 1990; Ridley and Hall, 1992) (see Chapter 6). Other approaches to study the effects of C3 in eukaryotic cells used expression of transfected C3 DNA (Hill et al., 1995), a C3 fusion toxin consisting of C3 and the receptor and translocation domain of diphtheria toxin (Aullo et al.,
1993), and permeabilization of cells before C3 treatment (Koch etal.,
1994). However, most studies exploited the property of C3 of entering most cells when applied at rather high concentrations (30-150 (Ag/ml) (Wiegers etal., 1991 ; Nishiki etal., 1990). Additionally, it appears that some C3 isoforms are somewhat more capable of entering culture cells. In some studies, effects of C3 were even observed at low concentrations (0.5 to 1 ^g/ml) of the transferase (Sugai etal., 1992). So far, it is not clear whether these effects are caused by different C3 isoforms or by specific conditions of cell culture (serum-free treatment).
Abo A, Pick E, Hall A et al. (1991): Activation of the NADPH oxidase involves the small GTP-binding protein p21rac. In Nature 353: 668-70 Aktories K, Weller U, Chhatwal GS (1987): Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin. In FEBS Lett. 212: 109-13
Aktories K, Just I, Rosenthal W (1988a): Different types of ADP-ribose protein bonds formed by botulinum C2 toxin, botulinum ADP-ribosyltransferase C3 and pertussis toxin. In Biochem. Biophys. Res. Commun. 156: 361-7 Aktories K, RösenerS, Blaschke U etal. (1988b): Botulinum ADP-ribosyltransferase C3. Purification of the enzyme and characterization of the ADP-ribosylation reaction in platelet membranes. In Eur. J. Biochem. 172: 445-50 Aktories K, Braun U, Rösener S et al. (1989): The rho gene product expressed in £ coli is a substrate of botulinum ADP-ribosyltransferase C3. In Biochem. Biophys. Res. Commun. 158: 209-13 Aktories K, Jung M, Böhmer J et al. (1995): Studies on the active site structure of C3-like exoenzymes: Involvement of glutamic acid in catalysis of ADP-ribosylation. In Biochimie 77: 326-32 Aktories K, Just I (1993): GTPases and actin as targets for bacterial toxins. In GTPases in biology I, (Dickey BF, Birnbaumer L., eds) pp. 87-112 BerlinHeidelberg: Springer-Verlag Aktories K, Just I (1995): In vitro ADP-ribosylation of Rho by bacterial ADP-
ribosyltransferases. In Methods Enzymol. 256: 184-95 Aullo P, Giry M, Olsnes S et al. (1993): A chimeric toxin to study the role of the 21 kDa GTP binding protein rho in the control of actin microfilament assembly. In EMBO J. 12: 921 -31
Bokoch GM (1994): Regulation of the human neutrophil NADPH oxidase by the
Rae GTP-binding proteins. In Curr. Opin. Cell Biol. 6: 212-8 Bourmeyster N, Stasia M-J, Garin J et al. (1992): Copurification of rho protein and the rho-GDP dissociation inhibitor from bovine neutrophil cytosol. Effect of phosphoinositides on rho ADP-ribosylation by the C3 exoenzyme of Clostridium botulinum. In Biochemistry 31: 12863-9 Bourne HR, Sanders DA, McCormick F (1990): The GTPase superfamily: a conserved switch for diverse cell functions. In Nature 348: 125—32 Bourne HR, Sanders DA, McCormick F (1991): The GTPase superfamily: conserved structure and molecular mechanism. In Nature 349: 117-27
Böhmer J, Jung M, Sehr P et al. (1996): Active site mutation of the C3-like ADP-ribosyltransferase from Clostridium limosum - Analysis of glutamic acid 174. In Biochemistry 35: 282-9 Braun U, Habermann B, Just I et al. (1989): Purification of the 22kDa protein substrate of botulinum ADP-ribosyltransferase C3 from porcine brain cytosol and its characterization as a GTP-binding protein highly homologous to the rho gene product. In FEBS Lett. 243: 70-6 Chardin P, Boquet P, Madaule P et al. (1989): The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. In EMBOJ. 8: 1087-92 Chong LD,Traynor-Kaplan A, Bokoch GM eta/. (1994): The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. In Cell 79: 507-13 Didsbury J, Weber RF, Bokoch GM et al. (1989): Rae, a novel ras-related family of proteins that are botulinum toxin substrates. In J. Biol. Chem. 264: 16378-82 Feig LA (1994): Guanine-nucleotide exchange factors: A family of positive regulators of Ras and related GTPases. In Curr. Opin. Cell Biol. 6: 204-11 Habermann B, Mohr C, Just I et al. (1991): ADP-ribosylation and de-ADP-ribosylation of the rho protein by Clostridium botulinum exoenzyme C3. Regulation by EDTA, guanine nucleotides and pH. In Biochim. Biophys. Acta 1077: 253-8
Hall A (1994): Small GTP-binding proteins and the regulation of the actin cytoskele-
ton. InAnnu. Rev. Cell Biol. 10: 31-54 Hauser D, Gibert M, Eklund MW et al. (1993): Comparative analysis of C3 and botulinal neurotoxin genes and their environment in Clostridium botulinum types C and D. In J. Bacteriol. 175: 7260-8 Hill CS, Wynne J, Treisman R (1995): The Rho family GTPases RhoA, Racl, and
CDC42Hs regulate transcriptional activation by SRF. In Cell 81: 1159-70 Hirata K, Kikuchi A, Sasaki T et al. (1992): Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. In J. Biol. Chem. 267: 8719-22
Inoue S, Sugai M, Murooka Yet a/. (1991): Molecular cloning and sequencing of the epidermal cell differentiation inhibitor gene from Staphylococcus aureus. In Bio-chem. Biophys. Res. Commun. 174: 459-64 Isomura M, Kikuchi A, Ohga N et al. (1991): Regulation of binding of rhoB p20 to membranes by its specific regulatory protein GDP dissociation inhibitor. In Oncogene 6: 119-24 Jung M, Just I, van Damme J et al. (1993): NAD-binding site of the C3-like ADP-
ribosyltransferase from Clostridium limosum. Inj. Biol. Chem. 268: 23215-8 Just I, Mohr C, Schallehn G et al. (1992a): Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum. In J. Biol. Chem. 267: 10274-80
Just I, Schallehn G, Aktories K (1992b): ADP-ribosylation of small GTP-binding proteins by Bacillus cereus. In Biochem. Biophys. Res. Commun. 183: 931-6 Just I, Mohr C, Habermann B et al. (1993): Enhancement of Clostridium botulinum C3-catalyzed ADP-ribosylation of recombinant rhoA by sodium dodecyl sulfate. In Biochem. Pharmacol. 45: 1409-16 Just I, Selzer J, Jung M et al. (1995): Rho-ADP-ribosylating exoenzyme from Bacillus cereus -purification, characterization and identification of the NAD-binding site. In Biochemistry 34: 334-40 Khosravi-Far R, Solski PA, Clark GJ et al. (1995): Activation of Racl, RhoA, and mitogen-activated protein kinases is required for Ras transformation. In Mol. Cell. Biol. 15: 6443-53 Kikuchi A, Kuroda S, Sasaki T et al. (1992): Functional interactions of stimulatory and inhibitory GDP/GTP exchange proteins and their common substrate small GTP-binding protein. Inj. Biol. Chem. 267: 14611-5 Kimura K, Ito M, Amano M eta/. (1996): Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). In Science 273: 245-8 Koch G, Norgauer J, Aktories K (1994): ADP-ribosylation of Rho by Clostridium limosum exoenzyme affects basal but not N-formyl-peptide-stimulated actin polymerization in human myeloid leukaemic (HL60) cells. In Biochem. J. 299: 775-9
Koch-Nolte F, Petersen D, Balasubramanian S eta/. (1996): MouseTcell membrane proteins Rt6-1 and Rt6-2 are arginine protein mono(ADPribosyl)transferases and share secondary structure motifs with ADP-ribosylating bacterial toxins. In J. Biol. Chem. 271: 7686-93 Kozma R, Ahmed S, Best A et a I. (1995): The Ras-related protein Cdc42Hs and bra-dykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. In Mol. Cell. Biol. 15: 1942-52 Lamarche N, Hall A (1994): GAPs for rho-related GTPases. In Trends Genet. 10: 436-40
Laudanna C, Campbell JJ, Butcher EC (1996): Role of Rho in chemoattractant-
activated leukocyte adhesion through integrins. In Science 271: 981 -3 Machesky LM, Hall A (1996): Rho: a connection between membrane receptor signalling and the cytoskeleton. In Trends Cell Biol. 6: 304-10 Maehama T, Ohoka Y, Ohtsuka T et a/. (1990): Botulinum ADP-ribosyltransferase activity as affected by detergents and phospholipids. In FEBS Lett. 263: 376-80 Malcolm KC, Ross AH, Qiu R-G et al. (1994): Activation of rat liver phospholipase
D by the small GTP-binding protein RhoA. In J. Biol. Chem. 269: 25951 -4 Moriishi K, Syuto B, Yokosawa N et al. (1991): Purification and characterization of ADP-ribosyltransferases (Exoenzyme C3) of Clostridium botulinum type C and D strains. In J. Bacteriol. 173: 6025-9 Moriishi K, Syuto B, Saito M et al. (1993): Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenized organisms. In Infect. Immun. 61: 5309-14 Nemoto Y, Namba T, Kozaki S et al. (1991): Clostridium botulinum C3 ADP-
ribosyltransferase gene. In J. Biol. Chem. 266: 19312-9 NishikiT, Narumiya S, Morii N eta/. (1990): ADP-ribosylation of the rho/rac proteins induces growth inhibition, neurite outgrowth and acetylcholine esterase in cultured PC-12 cells. In Biochem. Biophys. Res. Commun. 167: 265-72 Nobes C, Hall A (1994): Regulation and function of the Rho subfamily of small
GTPases. In Curr. Opin. Genet. Dev. 4: 77-81 Nobes CD, Hall A (1995): Rho, Rae, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. In Cell 81: 53-62 Okazaki IJ, Zolkiewska A, Nightingale MS et al. (1994): Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases. In Biochemistry 33: 12828-36 Olson MF, Ashworth A, Hall A (1995): An essential role for Rho, Rae, and Cdc42
GTPases In cell cycle progression through Gv In Science 269: 1270-2 Overbeck AF, Brtva TR, Cox AD et al. (1995): Guanine nucleotide exchange factors: Activators of Ras superfamily proteins. In Mol. Reprod. Dev. 42: 468-76 Paterson HF, Self AJ, Garrett MD eta/. (1990): Microinjection of recombinant p21rho induces rapid changes in cell morphology. In J. Cell Biol. Ill: 1001-7 Peppelenbosch MP, Qiu R-G, De Vries-Smits AMM et al. (1995): Rae mediates growth factor-induced arachidonic acid release. In Cell 81: 849-56 Popoff MR, Boquet P, Gill DM et al. (1990): DNA sequence of exoenzyme C3, an ADP-ribosyltransferase encoded by Clostridium botulinum C and D phages. In Nucl. Acids Res. 18: 1291 Popoff MR, Hauser D, Boquet P et al. (1991): Characterization of the C3 gene of Clostridium botulinum types C and D and its expression in Escherichia coli. In Infect. Immun. 59: 3673-9 Qiu R-G, Chen J, Kirn D et al. (1995): An essential role for Rae in Ras transformation. In Nature 374: 457-9 Qiu RG, Chen J, McCormick F eta/. (1995): A role for Rho in Ras transformation. In
Proc. Natl. Acad. Sei. USA 92: 11781-5 Quilliam LA, Khosravi-Far R, Huff SY et al. (1995): Guanine nucleotide exchange factors: Activators of the Ras superfamily of proteins. In Bioessays 17: 395-404
Regazzi R, Kikuchi A, Takai Y et al. (1992): The small GTP-blnding proteins in the cytosol of Insulin-secreting cells are complexed to GDP dissociation inhibitor proteins. In J. Biol. Chem. 267: 17512-9 Ridley AJ, Paterson HF, Johnston CL eta/. (1992): The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. In Cell 70: 401 -10 Ridley AJ, Hall A (1992): The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. In Cell 70. 389-99
Rubin EJ, Gill DM, Boquet Petal. (1988): Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. In Mol. Cell. Biol. 8: 418-26 Saito Y, Nemoto Y, IshizakiTeta/. (1995): Identification of Glu173 as the critical amino acid residue for the ADP-ribosyltransferase activity of Clostridium botulinum C3 exoenzyme. In FEBS Lett. 371: 105-9 Schmalzing G, Richter HP, Hansen A et al. (1995): Involvement of the GTP binding protein Rho in constitutive endocytosis in Xenopus laevis oocytes. In J. Cell Biol. 130: 1319-32
Sekine A, Fujiwara M, Narumiya S (1989): Asparagine residue in the rho gene product is the modification site for botulinum ADP-ribosyltransferase. In J. Biol. Chem. 264: 8602-5
Sugai M, Hashimoto K, Kikuchi A et al. (1992): Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. In J. Biol. Chem. 267: 2600-4 Takai Y, Sasaki T, Tanaka K et al. (1995): Rho as a regulator of the cytoskeleton. In
Trends Biochem. Sei. 20: 227-31 Tominaga T, Sugie K, Hirata M et al. (1993): Inhibition of PMA-induced, LFA-1-dependent lymphocyte aggregation by ADP-ribosylation of the small molecular weight GTP binding protein, rho. In J. Cell Biol. 120: 1529-37 Wiegers W, Just I, Müller H et al. (1991): Alteration of the cytoskeleton of mammalian cells cultured in vitro by Clostridium botulinum C2 toxin and C3 ADP-ribosyltransferase. In Eur. J. Cell Biol. 54: 237-45 Williamson KC, Smith LA, Moss J et al. (1990): Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. In J. Biol. Chem. 265: 20807-12 Zhang J, King WG, Dillon S et al. (1993): Activation of platelet phosphatidylinosi-tide 3-kinase requires the small GTP-binding protein Rho. In J. Biol. Chem. 268: 22251 -4
Copyright © 2002 WILEY-VCH Verlag GmbH & Co. KGaA
Was this article helpful?
When it comes to reducing wrinkles, you really have to take your needs seriously. There are a number of factors that play a role in the health and well being of your skin. It is often hard to understand how products work and why they may not work even if they promise to do so. If you are considering wrinkle creams and a regimen of facelifts, you may go broke in the process. Before you do all of that, consider going through a process of determine the very best solution for your needs.